ATRIAL FIBRILLATION MARKET Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION Atrial Fibrillation Market Overview Atrial fibrillation or A-fib or AF is an irregular heart beat exemplified by rapid and abnormal beating of the heart. The process usually starts as short periods of uncharacteristic beating that become elongated and constant over a period of time. Most episodes have little or no symptoms. Intermittently there can be palpitations in the heart, lightheadedness, fainting, chest pain, or shortness of breath, among others. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Valvular heart disease and high blood pressure are some of the common risk factors for atrial fibrillation. Some of the other risk factors related to heart include coronary artery disease, heart failure, congenital heart disease, and cardiomyopathy. In emerging economies, valvular heart disease mainly occurs due to rheumatic fever. High alcohol intake, thyrotoxicosis, and diabetes mellitus are some of the other factors. Diagnoses include checking the pulse and post-pulse measurement, an electrocardiogram (ECG) may confirm the presence of the disease. A distinctive ECG in atrial fibrillation does not show P waves and they indicate an abnormal ventricular rate. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/205 According to CDC, it is estimated that 2.7–6.1 million individuals in the U.S. alone suffer from atrial fibrillation. The report further states that the number is likely to increase with the aging of the population in this region. Roughly 2% of the population who are younger than 65 years of age suffers from AF. © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION However, around 9% of the population aged 65 years or more suffers from AF. The global market for atrial fibrillation is expected to grow at a steady pace, owing to the rise in the number of AF patients, caused primarily by common diseases and health conditions such as diabetes, obesity, and hypertension. Prevalence is especially highly among the geriatric population. Increasing cases of AF among the global population coupled with rising importance of catheter ablation procedures is expected to fuel growth of the atrial fibrillation market over the forecast period (2016–2024). Increasing prevalence of atrial fibrillation, especially among the geriatric population to drive growth of the overall atrial fibrillation market Rise in life expectancy among the global population has led to an increase in occurrence of AF in geriatric population. Also, rise in inclination for catheter ablation and technological advancements will fuel the market growth of atrial fibrillation market. Nonetheless, lack of skilled professionals and hostile first choice of pharmaceutical interventions over AF healing devices are projected to encumber the growth of the atrial fibrillation market size. According to the National Center for Biotechnology Information (NCBI), the prevalence of AF is estimated to double in a span of two decades (2010–2030). Favorable regulatory steps such as “National Programme for Prevention and Control of Diabetes, Cardiovascular Diseases and Stroke (NPDCS)” undertaken by the Government of India, which aims to prevent and control premature mortality and morbidity from cardiovascular diseases, stroke and diabetes mellitus. These factors governing the market along with rise in total number of AF cases will propel growth of the market during the forecast period. Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/205 © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION North America is the largest revenue contributor towards the global atrial fibrillation market share. Presence of advanced healthcare facilities and higher adoption rate of technologically advanced technologies in countries such as U.S. and Canada are some of the factors responsible for the dominance of the market in this region. The market in Asia Pacific is projected to grow at a substantial rate in the near future, owing to the region’s growing population and rapidly aging population highly vulnerable to heart diseases. Also, demand for atrial fibrillation treatment devices is estimated to increase, owing to the advancements in healthcare infrastructure and rise in expenditure in the emerging economies such as China and India thereby, fueling overall growth of the global atrial fibrillation market over the forecast period. Get Exclusive Discount on this CMI Report: https://www.coherentmarketinsights.com/insight/request-discount/205 Some of the major companies operating in the atrial fibrillation market in the current scenario are Cardiofocus, Inc., Biosense Webster, Inc., Biotitic Se & Co. Kg, St. Jude Medical, Inc., Medtronic, Inc., Carima, Inc., Boston Scientific Corporation, Ncontact, Inc., and Agricore, Inc. © Coherent market Insights. All Rights Reserved ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH MARKET INTELLIGENCE SERVICES CONSULT STUDIES COUNTRY SPECIFIC STUDIES © Coherent market Insights. All Rights Reserved ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved KEY STATS RESEARCH SOLUTIONS 100+ FEASIBILITY STUDIES Insights Published Per Year GLOBAL REPORTS 150+ Consulting Projects Till Date COUNTRY ANALYSIS CONSULT PROJECTS 125+ Clients Worldwide Per Year 110+ SURVEY RESEARCH EXCEL FORECAST DATABASE CUSTOMIZED SOLUTIONS COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

Atrial fibrillation or A-fib or AF is an irregular heart beat exemplified by rapid and abnormal beating of the heart. The process usually starts as short periods of uncharacteristic beating that become elongated and constant over a period of time. Most episodes have little or no symptoms. Intermittently there can be palpitations in the heart, lightheadedness, fainting, chest pain, or shortness of breath, among others. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Valvular heart disease and high blood pressure are some of the common risk factors for atrial fibrillation.